Antiviral Treatment of Coronavirus Disease-2019 Pneumonia

Direct acting antivirals and monoclonal antibodies reduce morbidity and mortality associated with severe acute respiratory syndrome coronavirus 2 infection. Persons at higher risk for disease progression and hospitalized patients with coronavirus disease-2019 (COVID-19) benefit most from available t...

Descripción completa

Detalles Bibliográficos
Autores principales: Radcliffe, Christopher, Malinis, Maricar, Azar, Marwan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701636/
https://www.ncbi.nlm.nih.gov/pubmed/37085220
http://dx.doi.org/10.1016/j.ccm.2022.11.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701636/
https://www.ncbi.nlm.nih.gov/pubmed/37085220
http://dx.doi.org/10.1016/j.ccm.2022.11.008

Ejemplares similares